Daré Bioscience, Inc. DARE
0.65 USD -0.01 -1.30%
As of Nov 3, 10:36 AM ET
- YTD
- -66.50%
- 1 year
- -66.33%
- Open
- 0.6431
- Prev close
- 0.655
- Mkt cap
- 12.72M
- Vol
- 20.89K
- Avg vol
- 506.93K
- EPS
- -0.71
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.64
- High
- 0.6533
- Forward P/E
- -2.35
- Beta
- 1.34
- Short ratio
- 0.64
- Inst. own
- 7.59%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 3.53
- 200-d avg
- 4.07
- 1y target
- 21.33
5D chart
Chart tools
Chart is warming up
The five-day price history for DARE has not been loaded yet. Try again in a moment.
Altman Z-Score
-13.47 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 3
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
P/E -1.6×
P/S 209×
P/B 75.9×
P/FCF -21.0×
EV/EBITDA -18.6×
EV/Sales 188×
FCF Yield -4.8%
Gross Margin -137.5%
Operating Margin -1315.5%
Net Margin -1300.7%
ROE -471.4%
ROIC -124.5%
ROA -41.3%
Revenue 10429.4%
Operating Income 42.2%
EPS (diluted) -150.0%
Free Cash Flow -313.0%
Current Ratio 1.1×
Quick Ratio 1.1×
Debt / Equity 0.9×
Net Debt / EBITDA 2.1×
Interest Coverage -16.5×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31